Adipokines--a future for therapeutic use?
Ziegler, R.
Medizinische Monatsschrift für Pharmazeuten 28(7): 257
2005
ISSN/ISBN: 0342-9601 PMID: 16038134 Document Number: 586643
Document emailed within 1 workday
Related Documents
Fietta, P.; Delsante, G. 2013: Focus on adipokines Theoretical Biology Forum 106(1-2): 103-129Marra, F.; Aleffi, S.; Bertolani, C.; Petrai, I.; Vizzutti, F. 2005: Adipokines and liver fibrosis European Review for Medical and Pharmacological Sciences 9(5): 279-284
Sawicka, K.; Krasowska, D. 2016: Adipokines in connective tissue diseases Clinical and Experimental Rheumatology 34(6): 1101-1112
Yamauchi, T.; Kadowaki, T. 2006: The roles of adipokines in the regulation of insulin sensitivity Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 9): 132-138
Rubbert, A.; Burmester, G.R. 1993: New therapeutic possibilities. Future aspects Der Internist 34(9): 841-851
Jero, J.; Aarnisalo, A. 2011: Future therapeutic options for inner ear diseases Duodecim; Laaketieteellinen Aikakauskirja 127(8): 848-853
Saito, Y. 2004: Therapeutic application of ANP: past and future Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 139-146
Al Awadhi, S.A.; Al Khaldi, R.M.; Al Rammah, T.; Kapila, K.; Mojiminiyi, O.A. 2012: Associations of adipokines & insulin resistance with sex steroids in patients with breast cancer Indian Journal of Medical Research 135(4): 500-505
Davis, K.L. 1998: Future therapeutic approaches to Alzheimer's disease Journal of Clinical Psychiatry 59(Suppl): 14-16
Casalini, P.; Iorio, M.V. 2009: MicroRNAs and future therapeutic applications in cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 14(Suppl 1): S17-S22
Krogh, I.; Moller, B.; Niebuhr, E.; Nielsen, B.; Wamberg, E. 1974: Future therapeutic work with oligophrenic patients Sygeplejersken 74(15): 13-19
Sela, M.; Arnon, R.; Schechter, B. 2002: Therapeutic vaccines: realities of today and hopes for the future Drug Discovery Today 7(12): 664-673
Perbeck, L. 1998: Angiogenesis-inhibiting drugs--a future therapeutic option Nordisk Medicin 113(9): 297-298; 316
Edan, G.; Coustans, M. 2000: Is immunosuppression a future therapeutic strategy for multiple sclerosis? Pathologie-Biologie 48(2): 114-120
Kravchun, P.; Kadykova, O.; Gabisoniia, T. 2012: The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease Georgian Medical News 213: 26-31
Carstens, S.; Andersen, I. 1994: Intranasal glucagon in the treatment of hypoglycemia. a therapeutic possibility in the future Ugeskrift for Laeger 156(30): 4339-4342
Yunusova, N.V.; Kondakova, I.V.; Kolomiets, L.A.; S G Afanasiev; Chernyshova, A.L.; Shatokhina, O.V.; Frolova, A.E.; Zhou, Z.; Wang, W. 2015: Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis Voprosy Onkologii 61(4): 619-623
Urbanovych, A.; Suslyk, G. 2018: Correlation between adipokines and mediators of non-specific inflammation in type 2 diabetic patients depending on the glycaemic control Wiadomosci Lekarskie 71(6): 1169-1174
Bulbrook, M.J. 1984: Bulbrook's model of therapeutic touch: one form of health and healing in the future Canadian Nurse 80(11): 32-34
Alvarez Muñoz, P.; López Novoa, J.M. 2007: Interference RNA: a curiosity that merits a Nobel price or a future therapeutic tool Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(3): 241-248